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ABSTRACT
Mouse transgenesis has proven invaluable for
analysis of gene function and generation of human
disease models. We describe here the development
of a pronuclear injection-based targeted
transgenesis (PITT) system, involving site-specific
integration in fertilized eggs. The system was
applied to two different genomic target loci to
generate a series of transgenic lines including fluor-
escent mice, which reproducibly displayed strong,
ubiquitous and stable transgene expression.
We also demonstrated that knockdown mice could
be readily generated by PITT by taking advantage of
the reproducible and highly efficient expression
system. The PITT system, which circumvents the
problem of unpredictable and unstable transgene
expression of conventional random-integration
transgenic mice, reduces the time, cost and effort
needed to generate transgenic mice, and is poten-
tially applicable to both in vivo ‘gain-of-function’ and
‘loss-of-function’ studies.
INTRODUCTION
Transgenic mice have been extensively used for in vivo
analysis of gene function and generation of human
disease models (1). Pronuclear injection (PI) is the most
common method used to generate transgenic mice (2,3),
although the wide variability in the level and pattern of
transgene expression that can inﬂuence the phenotype
often varies strongly, due to the random nature of copy
number, conﬁguration and integration site of the trans-
gene (4,5). The effect of the insertion site on the transgene
expression can be minimized by including insulator
sequences into the transgenic construct (6,7), or by using
large DNA constructs such as Bacterial Artiﬁcial
Chromosome (BAC) (8). Even in such strategies, trans-
gene insertion can alter the expression and/or function
of endogenous genes at the integrated region. Therefore,
researchers must produce at least ﬁve lines for screening
of lines with adequate transgene expression and for
obtaining reproducible and ﬁrm results. The targeted
integration of a single-copy transgene has become
recently possible through homologous recombination or
site-speciﬁc recombination in embryonic stem (ES) cells.
Such targeted transgenesis is advantageous for achieving
predictable and reproducible transgene expression
(4,9,10). However, the targeted system is more technically
demanding and time-consuming than PI-based
transgenesis.
The present study established a PI-based targeted
transgenesis(PITT)systembasedonsite-speciﬁcrecombin-
ation in fertilized eggs, but not in ES cells. By applying our
PITT method, we established a number of transgenic lines,
including ﬂuorescent mice of which transgene expression
was both predictable and reproducible. We also successful-
ly applied the technique to generate knockdown mice.
Because of its simplicity and time- and cost-effectiveness,
the PITT system is a potentially useful ﬁrst choice to
achieve ‘gain-of-function’ and ‘loss-of-function’ of gene
of interests.
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Plasmid construction
The sequences and maps of the plasmids used in the
present study are available upon request. Plasmids
containing site-speciﬁc recombination sites, drug-resistant
genes,reportergenesandothercomponentsweregenerated
through a multi-step process of ligation-based cloning.
Site-speciﬁc recombination sites, FRT, JT15, JTZ17 (11)
and lox2272 (12), were generated by using synthesized
oligos. Neomycin-resistant gene (neo), hygromycin-
resistant gene (hyg), EGFP gene, lacZ gene, internal
ribosome entry site (IRES) sequence, tau and splice
acceptor (SA) site were derived from pPGK-neo-loxP
(Gene Bridges, Heidelberg, Germany), pJR225, pCE-29
(13), pIZA2 (kindly provided by Dr Noguchi, Meiji
Milk Co., Tokyo, Japan), pCAGGS-FLPe (14) (Gene
Bridges), tauEGFP plasmid (kindly provided
by Dr Hitoshi Sakano) and pSAbgeo (15) (kindly
provided by Dr Philippe Soriano), respectively. The genes
encoding ﬂuorescent proteins used in this study were either
kindly provided by Dr Roger Tsien (tdTomato, mCFP,
mCitrine) (16–18) or purchased from Clontech
(Mountain View, CA) (mOrange, pECFP-Nuc,
pEYFP-Nuc) and MBL (Nagoya, Japan) (Kikume
Green-Red). The nucleotide sequences of junctional
portions after cloning and PCR-ampliﬁed regions were
conﬁrmed by sequencing.
The plasmids used to check for possible recombin-
ation between heterotypic lox sites were generated as
follows. The SacB gene (pDNR-Dual, Clontech) was
ampliﬁed by PCR using the primer sets M730 and
M734, M730 and M735, M731 and M736, M732
and M736, and M733 and M736 (Supplementary
Table S1). The ampliﬁed fragments were cloned into
the SmaI site of pUC119 vector, generating pAYT
(loxP-loxP), pAYU (loxP-lox511), pAYV (JT15-
lox2272), pAYW (JTZ17-lox2272) and pAYX (JT15/
JTZ17-lox2272).
The targeting construct for H2-Tw3 gene (19)
was generated by modifying the citb585c7 BAC clone
(from a CITB library derived from the 129/SV mouse
strain, Research Genetics/Invitrogen, Carlsbad, CA,
USA) using recombineering method with the DY380
Escherichia coli (20) and the plasmids, pADY and pAEF
(21). The protocols for recombineering fragments, of
which homology regions (HRs) were PCR-ampliﬁed
from the BAC clone with the following primer
sets: (M393 and M394 for HR1, M395 and M396 for
HR2, M397 and M398 for HR3 and M399 and M155
for HR4; Supplementary Table S1), were generated
based on the protocols described previously by our
group (21). The recombineering protocol was based on
the protocol of Liu et al. (20). The resulting targeting
vector (pAFP) had the following components in a 50 to
30 direction: I-SceI site, long arm, FRT, PGK-Tn5
promoter, neo, JT15, IRES, ECFP-Nuc, polyA site,
lox2272, short arm and diphtheria toxin fragment A
(DT-A) cassette.
The targeting construct for Rosa26 locus (22) was
generated as follows. BAC clones containing this locus
were obtained by PCR screening of 129/Ola BAC library
(23). The BAC clone 124I18 was used for recombineering.
HRs for recombineering fragments were PCR-ampliﬁed
from the BAC clone with the following primer sets:
M058 and M057 for HR1, M056 and M055 for HR2,
M060 and M059 for HR3 and M054 and M053
for HR4 (Supplementary Table S1). Recombineering
fragments were prepared according to the method
described previously by our group (21), and used for
targeting vector construction. The resulting targeting
vector (pAIW) had the following components in a 50 to
30 direction: DT-A cassette, short arm, SA, FRT sequence-
fusion neo, JT15, IRES, ECFP-Nuc, polyA site, lox2272,
long arm and I-SceI site.
The donor vectors had the following components in
a5 0 to 30 direction: hygromycin-resistance cassette (CAG
promoter, hyg, polyA site), FRT, DNA of interest (DOI),
lox2272, JTZ17, IRES, reporter gene, polyA site and a
plasmid backbone. As for the promoterless reporter
gene, lacZ gene was used for pAJK, pAMF, pAKB,
pAMG, pAMJ, pANQ, pAOB, pAOF, pAOK, pAOL,
pAOM, pAOT and pAOU, EGFP gene was used for
pA748 and EYFP-Nuc gene was used for pA617.
In the DOI region, the following cassettes were included
in each donor vector: ‘dual SacB genes with GFPuv’
(21) in pAJK and pA748, ‘CMV-HcRed1-polyA’
in pA617, ‘CAG-EGFP-polyA’ in pAMF, ‘FRT-fusion
EGFP-polyA’ in pAKB, ‘CAG-EGFP-miR(Hr-1)-polyA’
in pAMG, ‘CAG-EGFP-miR(Hr-2)-polyA’ in pAMJ,
‘CAG-tau/kikume-polyA’ in pANQ, ‘CAG-mCherry-
polyA’ in pAOB, ‘CAG-mCitrine-polyA’ in pAOF,
‘CAG-mCFP-polyA’ in pAOK, ‘CAG-mOrange-polyA’
in pAOL, ‘CAG-tdTomato-polyA’ in pAOM, ‘CAG-
EGFP-miR(Tyr-1/2)-polyA’ in pAOT and ‘CAG-EGFP-
miR(Tyr-3/4)-polyA’ in pAOU.
Tests for possible recombination between heterotypic
lox sites
In these experiments, 1/50 volume of the vectors (pAYT,
pAYU, pAYV, pAYW and pAYX) isolated from 5ml of
overnight culture, was incubated at 37 C for 60min with
1U of Cre recombinase (New England Biolabs, Beverly,
MA, USA) in a total volume of 10ml. After incubation of
the reaction mixture at 70 C for 10min, the presence of
Cre-mediated recombination was checked by PCR with
primer set M272 and M322 (Supplementary Table S1)
using 0.5ml of reaction mixture as template. From
recombined and non-recombined plasmid, 262-bp and
2225-bp fragments were ampliﬁed, respectively.
Furthermore, 0.5ml of Cre reaction mixture was also
transformed into 5ml of DH5a (TaKaRa). Following
incubation at 37 C in SOC medium, one-ﬁfth of the
samples were plated on LB plates containing ampicillin
(100mg/ml), sucrose (7%) and 1/200th of the samples
was plated on LB plates containing ampicillin (100mg/
ml). Colonies were counted, and those on ampicillin/
sucrose plates were subjected to PCR analysis with
M272 or M322 primer set.
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The H2-Tw3 targeting vector (20mg) linearized with I-SceI
was introduced into 1 10
7 E14tg2a ES cells (24) by
electroporation. G418-resistant ES cell colonies were
picked and subjected to the ﬁrst screening by PCR with
primers #145 and M400 (Supplementary Table S1).
The presence of correctly targeted clones was conﬁrmed
by Southern blot analysis using a
32P-labeled probe
generated by random prime labeling of PCR product
ampliﬁed from BAC DNA with primers M153 and
M154 (Supplementary Table S1). One of the targeted ES
clones (3D2) was microinjected into the blastocoels of
mouse F1 (C57BL/6J BDF1) blastocysts to produce
chimeric mice. Germ-line transmission was conﬁrmed
by crossing male chimeric mice to C57BL/6J female
mice. Heterozygous mice were intercrossed to obtain
homozygous mice. Genotyping of the targeted allele was
performed by PCR with primer set #166 and #142
(Supplementary Table S1). The H2-Tw3 wild-type allele
was detected by TaqI digestion of the PCR product
ampliﬁed with primer set M401 and M402
(Supplementary Table S1).
With regard to the Rosa26 locus, the knock-in vector
(20mg) linearized with I-SceI was introduced into 1 10
7
E14tg2a ES cells by electroporation. G418-resistant ES
cell colonies were picked and subjected to the ﬁrst
screening by PCR with primers M195 and M024
(Supplementary Table S1). Two of the obtained targeted
ES clones (2A5 and 3D6) were microinjected into mouse
F1 (C57BL/6J BDF1) blastocysts. Germ-line transmis-
sion was conﬁrmed by crossing male chimeric mice with
C57BL/6J female mice. The heterozygous mice were inter-
crossed to obtain homozygous mice. The wild-type and
targeted allele were genotyped by PCR with primers
#145, M273 and M274 (Supplementary Table S1), which
gave rise to 429-bp fragment from the wild-type allele and
522-bp fragment from the targeted allele. The presence of
successfully targeted mice was conﬁrmed by Southern blot
analysis using a DIG-labeled probe ampliﬁed by PCR
from BAC DNA with primers M372 and M373 for
short arm, and M374 and M375 for long arm
(Supplementary Table S1).
RMCE in ES cells
Two methods for delivery of plasmid DNA to ES cells
were used in this study; electroporation and lipofection.
In all experiments, including those of gene targeting, ES
cells were cultured in the presence of feeder cells derived
from DR-4 strain (25). For electroporation, 5 10
6 of ES
cells carrying the targeted locus were electroporated with
10mg of Cre-expression vector (pCAG/NCre) (26) and
10mg of donor vector at 200V and 500mF. After 24h,
hygromycin was added to the medium to a ﬁnal concen-
tration of 200mg/ml to begin selection. Individual clones
were picked about 1 week after electroporation, grown in
24-well plates, and ﬁnally expanded to generate duplicate
plates for freezing, DNA analysis and/or X-gal staining
(X-Gal Staining Assay Kit: Genlantis). For lipofection,
1.5–2.6 10
5 of ES cells were seeded onto one well of
6-well plates. After 18h, 5mg of the donor vector was
Lipofectamin 2000 (Invitrogen)-treated with or without
5mg of pCAG/NCre, according to the user manual
supplied by the manufacturer. The next day, hygromycin
selection (200mg/ml) was initiated. One or 2 days after
transfection, ES cells were re-plated onto 10-cm dishes
and hygromycin selection continued. Colonies were
stained with X-gal and others were picked up for cell
propagation used for cell freezing and DNA analysis.
Only EGFP-ﬂuorescent ES colonies were picked for trans-
fection with pA748.
PITT
Donor plasmids and pCAG/NCre were prepared using a
HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany).
The optimal concentrations of Cre plasmids for PI were
determined by injecting various concentrations (1, 2.5, 5
and 10ng/ml) of pCAG/NCre into the fertilized eggs
obtained from mating ICR female and BDF1 male mice.
The injected eggs were cultured up to blastocyst stage,
and the concentration of pCAG/NCre (5ng/ml), which
allowed >70% eggs to survive, was employed for further
experiments. The concentration of the donor vector used
for PITT was determined by injection of various concen-
trations (5, 10 and 20ng/ml) of pAOF and 5ng/mlo f
pCAG/NCre into the ICR BDF1 fertilized eggs. These
treated eggs were cultured up to the morula stage, and the
concentration of pAOF (5–10ng/ml), which allowed
>30% eggs to survive, was employed for PITT
experiments.
To perform PITT, the plasmid mixture was diluted to
10–15ng/ml (5 or 10ng/ml for donor vector and 5ng/ml for
Cre plasmid) in injection buffer (5mM Tris/0.1mM
EDTA, pH 7.5). The fertilized eggs were isolated from
super-ovulating BDF1 female mice that had been mated
with males of the H2-Tw3 or Rosa26 homozygous targeted
mice. The plasmid mixture was introduced into eggs by
microinjection using a standard protocol (27). The micro-
injected and surviving embryos were then cultured over-
night. The next day, embryos that developed into the
two-cell stage were transferred to the oviducts of a foster
mother. The resulting offspring was then analyzed for the
integration of the transgene into the genome at 3 weeks of
age, at the time of weaning.
Detection of successful RMCE in ES cells and mice
To detect correct RMCE in recombinants, the primer sets
were designed to amplify the junctional region generated
by recombination. RMCE-mediated integration of donor
vectors into the H2-Tw3 locus was checked by PCR using
the primer sets #169 and M396, and #166 and M159 for
pAJK integration, #169 and M396, and BbvI digestion of
PCR product ampliﬁed using primers #166 and M026 for
pA748 integration, M025 and M396 for pA617 integra-
tion, and #166 and M159, and M396 and M124 for
pAMF integration (Supplementary Table S1). X-gal
staining of ES clones was also conducted for recombinants
with pAJK and pAMF integrations. Donor vector inte-
gration into the Rosa26 locus was detected by PCR using
the primer sets #169 and M058, and BbvI digestion of
PCR product ampliﬁed using primers #166 and M026
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M159 for pAMF integration, #143 and M058, and #166
and M159 for pAKB integration, M124 and M274, and
#166 and M159 for pAMG, pAMJ, pANQ, pAOB,
pAOF, pAOK, pAOL, pAOM, pAOT and pAOU
integration (Supplementary Table S1). X-gal staining of
ES clones was also conducted for recombinants with
pAJK, pAMF or pAKB integration.
The founder mouse containing targeted transgene
integrated by partial RMCE event was crossed with
a CAG-Cre transgenic mouse (28) to obtain mice
with complete RMCE
ex allele. The possibility of random
integration of the donor vector and the Cre-expression
plasmid in founder pups was checked by PCR-based
assay using the primer sets M132 and M194, and #142
and M124 for the donor vector, and M515 and M581
for the Cre-expression plasmid (Supplementary Table S1).
Elimination of the extra sequence
FLPe-mediated excision of FRTed sequence including
vector sequence and marker genes was performed by
introducing FLPe expression plasmid, pCAGGS-FLPe
(14), or by crossing RMCE
ex mouse with FLPe transgenic
mouse (29). For the ES cells, pCAGGS-FLPe was trans-
fected into RMCE
ex cells using Lipofectamin 2000. After
selection with puromycin, colonies were picked, grown in
24-well plates, and expanded to generate duplicate plates
for cell freezing and DNA analysis. For the mouse with
RMCE
ex allele, pCAGGS-FLPe (5ng/ml) was introduced
into the pronuclei of fertilized eggs by microinjection,
and the treated eggs were then transferred to the foster
mother. Otherwise, RMCE
ex male mice were crossed with
FLPe transgenic female mice. The resulting offspring was
then analyzed for the removal of the FRTed sequence.
Excision of FRTed sequence was checked by PCR with
the primer sets M393 and #143 for pAMF integration into
the H2-Tw3 locus, M022 and M376 for pAMF, pAOF,
pAOK, pAOL, pAOM, pAOT integration into the Rosa26
locus (Supplementary Table S1), and some of them were
conﬁrmed by Southern blot analysis. The presence or
absence of FLPe transgene was conﬁrmed by PCR with
primer set M587 and M580 (Supplementary Table S1).
Mice
All mice were kept in the Center of Genetic Engineering
for Human Diseases (CGEHD) animal facility at
Tokai University School of Medicine. ICR, C57BL/6J
and BDF1 mice were obtained from CLEA Japan Inc.
(Tokyo, Japan). FLPe transgenic mouse strain
(RBRC01835) was provided by RIKEN BRC, which is
a participant in the National Bio-Resource Project of
the MEXT, Japan (29). CAG-Cre transgenic mouse
strain was kindly provided by Dr Jun-ichi Miyazaki (28).
Green mouse [C57BL/6-Tg(CAG-EGFP)] was obtained
from Japan SLC, Inc. (Hamamatsu, Japan) (30). The
H2-Tw3- and Rosa26-targeted mice described above
were maintained as homozygotes with a hybrid genetic
background of C57BL/6J and 129/Ola.
Observation of ﬂuorescence in color mice
The expression of ﬂuorescence in color mice was ﬁrst
examined by the naked eye under a long-wave UV light
(365nm). For ﬁgures (Figure 2B and C, and
Supplementary Figures S3 and S5), the images were
observed using the Olympus SZX12 Stereo Microscope
with ﬁlter sets for CFP (Ex438 Dm467-600 Em483),
GFP (SZX-MGFP; Ex460-490 Dm505 Em510) and
HcRed (SZX-MIY; Ex540-580 Dm600 Em610). For
Figure 4C and F, the images were obtained using a
Keyence BZ-9000 ﬂuorescence microscope with ﬁlter
sets (XF114-2; Ex440 Dm455 Em480, OP-66836;
Ex470/40 Dm495 Em535/50 and OP-66837; Ex540/25
Dm565 Em605/55). For Figure 4A, D and E, the images
were obtained using a Keyence ﬂuorescent stereo-
microscopy attached to a cooled CCD camera (VB-G05,
VB-7010/7000) with ﬁlter sets (OP-42316, OP-51576,
OP-42314V, OP-42311, OP-51571, OP-42312, OP-51572,
OP-42315 and OP-51575). All mice, except homozygote
EGFP transgenic mouse (Rosa26
CAG::EGFP) shown in
Supplementary Figure S6, were hemizygotes for the
transgene.
FACS analysis
Spleen cells were prepared and cleared of red blood cells
by osmotic lysis. The cells were then applied to ﬂow
cytometric analyses performed on a FACSCalibur (BD
Biosciences, San Diego, CA, USA). Data were analyzed
on a CellQuest program (BD Biosciences).
Histology
Adult tissue samples were dissected and ﬁxed overnight in
4% PFA, then equilibrated in 20% sucrose before
freezing. Frozen sections (8mm) were imaged directly for
EGFP ﬂuorescence.
Analyses of Tyrosinase knockdown mouse
The Tyrosinase (Tyr) knockdown mouse
(Rosa26
CAG::miR-Tyr) was generated by PITT (pAOT).
It contains a single copy of ‘CAG-EGFP-miR(Tyr-1/
2)-polyA’ cassette in Rosa26 locus. Artiﬁcial microRNA
(miRNA) region in pAOT is derived from ‘BLOCK-iT Pol
II miR RNAi Expression Vector Kit with EmGFP’
(K4936-00, Invitrogen) with two tandemly arranged
oligos for Tyr knockdown (50-GTAAAGCTGAAAT
TGGCAGTTCGTTTTGGCCACTGACTGACGAACT
GCCTTTCAGCTTTA-30 and 50-GTGGACTGGCA
AATCCTTCCAGGTTTTGGCCACTGACTGACCTG
GAAGGTTGCCAGTCCA-30). EGFP ﬂuorescence of
Rosa26
CAG::miR-Tyr mouse was observed under long-wave
UV light (365nm). Parafﬁn sections were prepared from
ﬁxed ears and eyes of Rosa26
CAG::miR-Tyr mouse and
wild-type littermate, and stained with Alcian Blue-
Kernechtrot (for ear) and hematoxylin-eosin (for eye).
The mRNA levels of Tyr in the ears and eyes of
Rosa26
CAG::miR-Tyr mouse and wild-type littermate
were assessed by SYBR-green-based real-time reverse
transcription (RT)–PCR, with ACTB (b-actin) used as
an internal control.
e198 Nucleic Acids Research, 2010,Vol.38, No. 22 PAGE 4 OF 11RESULTS
Basic strategy for targeted transgenesis system
The overall scheme of this system is shown in Figure 1A.
ES cells and mice with targeted alleles were initially
generated through ES cell targeting to contain
recombination-target sequences (loxP-site derivatives,
JT15 and lox2272 and FRT) at a predetermined locus.
A transgene, ﬂanked by the JTZ17 and lox2272 sites of
donor vector, was then integrated into target loci by
recombinase-mediated cassette exchange (RMCE) in ES
cells or fertilized eggs to generate RMCE
ex allele.
The donor vector also contained hygromycin-resistant
cassette (for the detection of both random and targeted
integration) and promoterless reporter cassette containing
lacZ or ﬂuorescent gene (for the detection of only targeted
integration) for selection in ES cells. Finally, the unneces-
sary sequence ﬂanked by FRT sequences was eliminated
by FLPe, resulting in a clean integrated DOI ﬂanked
only by FRT and lox2272 (RMCE
ex allele). Among
of the multitude of mutant loxP sites reported previously,
we chose the ‘JT15/JTZ17 (inverted-repeat variants)
and lox2272 (spacer variant)’ combination of loxPs,
based on previous studies describing (i) the combination
of ‘LE/RE inverted-repeat mutant and lox22720 showed
high recombination efﬁciency in ES cells (31) and (ii) the
JT15/JTZ17 mutant pair promotes the most efﬁcient inte-
gration without eliciting intramolecular recombination in
E. coli (11).
Veriﬁcation of JT15/JTZ17 and lox2272 Combination for
the targeted transgenesis in vitro and in ES cells
The particular combination of loxP derivatives, JT15/
JTZ17 and lox2272, was chosen to theoretically achieve
maximally efﬁcient RMCE with minimal undesired intra-
molecular recombination, although this particular com-
bination has not been tested before. This study ﬁrst
tested in vitro whether intramolecular recombination
occurs in this combination of loxP derivatives. For this
purpose, we prepared ﬁve plasmids containing SacB
gene, which provides a counter selection in E. coli,
ﬂanked by the ﬁve combinations of loxP derivatives
(Supplementary Figure S1A). After in vitro Cre treatment
of these plasmids, recombinations between loxP deriva-
tives were checked by two methods: direct PCR of Cre
reaction sample, and selection in E. coli grown on the
LB sucrose plate. In both tests, Cre-mediated recombin-
ation was detected not only in loxP/loxP but also in loxP/
lox511 as described previously (32,33), but no intramo-
lecular recombination was observed in the combinations
of loxP derivatives used in this study (Supplementary
Figure S1B and C).
To establish JT15-lox2272-tagged seed mice, we
modiﬁed the Rosa26 locus (conferring active and ubiqui-
tous gene expression) (22) and H2-Tw3 locus (conferring
tissue-speciﬁc expression) (19) using standard ES cell
targeting (Figure 1B). The targeting frequencies were
25% (for Rosa26) and 3% (for H2-Tw3).
We next examined RMCE efﬁciency in mammalian ES
cells by transfection of a donor plasmid carrying a
hygromycin-resistant cassette and promoterless reporter
gene ﬂanked by JTZ17 and lox2272 together with a
Cre-expression plasmid (Figure 1A). We used lacZ or
EGFP genes as promoterless reporter gene in a donor
plasmid, and its expression was initiated by PGK (for
H2-Tw3) or endogenous Rosa26 promoter (for Rosa26)
after integration into a tagged locus by correct recombin-
ation (Figure 1A). Among the hygromycin-resistant
colonies, 20–40% of the resistance was attributed to
correct RMCE (Supplementary Table S2). As expected,
correct RMCE, which can be readily assessed by
reporter gene expression, was dependent on the Cre
recombinase (Figure 2A and B). No signiﬁcant differences
in the integration efﬁciency were seen between the two loci
and between the two transfection methods (electropor-
ation or lipofection; Supplementary Table S2). These
results indicate the availability of JT15/JTZ17 and
lox2272 combination for the targeted transgenesis.
Stable transgene expression achieved by removal of extra
sequences
The RMCE
ex ES clones were isolated with EGFP expres-
sion cassette ‘CAG-EGFP-polyA’. However, the strength
of EGFP ﬂuorescence in these clones was weak and often
mosaic after several passages, probably due to promoter
interference and/or epigenetic silencing (Figure 2C, left).
Since the presence of extra sequences including vector
sequence and selection markers could affect the expected
transgene expression, the clones were next subjected to
removal of an extra sequence by administration of FLPe
(Figure 1A) (14). The resultant RMCE
"ex clones began to
exhibit strong and uniform EGFP ﬂuorescence after
removal of extra sequence (Figure 2C, left). This robust
EGFP ﬂuorescence was noted even after ﬁve passages.
This phenomenon was also observed in vivo. After
generating RMCE
ex transgenic mice from the RMCE
ex
ES clones carrying the EGFP expression cassette, the
FRT-ﬂanked segment was removed by FLPe to generate
RMCE
"ex alleles (34). FLPe recombinase was provided
either by PI at the zygote stage or by crossing with an
FLPe deleter mouse (Supplementary Figure S2) (14,29).
In the PI experiment, 69% and 58% of newborns with
modiﬁed allele showed FLPe recombination in H2-Tw3
and Rosa26 locus, respectively (Supplementary Figure
S2B). When RMCE
ex transgenic mice were crossed with
FLPe transgenic mice, all double transgenic progeny
obtained so far harbored RMCE
"ex alleles (Supplementary
Figure S2C). These results indicate that both approaches
were highly efﬁcient for our purpose of removing the
FRT-ﬂanked sequence in vivo. This elimination step was
necessary because EGFP expression driven by a CAG
promoter in RMCE
ex alleles was weak, often mosaic, and
inconsistent, while mice with the RMCE
"ex allele showed
strong and ubiquitous EGFP expression as described
below (Figure 2C, right and Supplementary Figure S3).
Generation of targeted transgenic mouse lines by
Cre-loxP site-speciﬁc recombination in fertilized eggs
After conﬁrming in ES cells that a transgene can prefer-
entially integrate into the loxP-tagged loci by
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this ﬁgure) in the targeted allele by Cre-based RMCE via mutant loxP sites. Extra sequence in the RMCE
ex allele is removed by FLPe, resulting in an
RMCE
"ex allele. Red and blue, and the green arrowheads are the PCR primer sets used for detection of correct recombinant (Figure 3B).
(B) Targeted insertion of mutant loxP-tagged sequences into the H2-Tw3 and Rosa26 loci. H2-Tw3 and Rosa26 targeting vectors were introduced
into E14tg2a ES cells. G418-resistant clones were picked, and the targeted alleles were screened by PCR and certiﬁed by hybridization. Southern blot
analyses of genomic DNA from ES cells (H2-Tw3) and mice (Rosa26) are shown on the right side of the ﬁgure. Homologous recombinations at the
H2-Tw3 and Rosa26 loci are detectable using BglIo rBamHI-digested genomic DNAs by the probes marked by the red bars, respectively.
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Supplementary Table S2), seed mouse lines were estab-
lished from the Rosa26 and H2-Tw3-targeted ES cells.
Both homozygous and heterozygous lines carrying the
targeted alleles were viable and developed normally with
normal reproductive ability. Fertilized eggs were prepared
from homozygous seed male mice and wild-type females
to evaluate the success of PITT. We ﬁrst determined the
maximum concentration of Cre-expression plasmid and
found that 5ng/ml, but not 10ng/ml, could be injected
without signiﬁcant detrimental effects (Supplementary
Table S3). Subsequent titration of donor plasmid concen-
trations showed that up to 5–10ng/ml was tolerated
(Supplementary Table S4). Figure 3B summarizes the
results of microinjection of 11 different donor DNAs
into 3256 fertilized eggs. Among the 492 newborns
obtained, 21 (4.3%) showed targeted integration into the
tagged loci, detected by PCR assay (Figure 3B) and some
conﬁrmed by Southern blot (Supplementary Figure S4).
At least one transgenic founder was obtained for each of
the 11 donor DNAs tested. Although the majority of
transgenic founders (20/21) showed complete recombin-
ation generating correct RMCE
ex alleles (recombination
occurred in both loxP sites: JT15/JTZ17 and lox2272/
lox2272), one founder (pANQ in Figure 3A) exhibited
partial recombination (recombination occurred only via
JT15/JTZ17). In this case, we obtained complete
RMCE
ex allele by crossing partially recombined founder
with CAG-Cre transgenic mouse (data not shown) (28).
The Rosa26 seed mouse was used in the majority of
experiments, with the H2-Tw3 seed mouse used in one
trial. Correct recombinants were obtained in all cases
(Figure 3A), showing that PITT is not restricted to a par-
ticular locus. It is noteworthy that random integration of
the donor vector and/or the Cre-expression plasmid was
never detected in all targeted transgenic founders based on
PCR, indicating that site-speciﬁc integration event and
random integration event occur independently in mice
(data not shown).
Since the integration mechanism based on site-speciﬁc
recombination must be different from that on random in-
sertion, and the transgene integration by our system could
occur after two-cell stage following the induction of Cre
expression, it is important to examine the germ-line trans-
mission efﬁciency to verify this method for the generation
of stable transgenic mouse lines. Therefore, we next
evaluated the germ-line transmission of transgenes in 21
founder mice generated. Germ-line transmission was
detected with 18 lines from 21 founder mice tested
(>85%), indicating an efﬁciency comparable to that
achieved with conventional transgenesis (e.g. 82%) (35).
Figure 2. Efﬁcient detection of correct RMCE recombinants in ES
cells, and EGFP expression in RMCE
ex and RMCE
ex alleles.
(A) The rate of appearance of the background clones. Donor vector,
which contains lacZ gene as promoterless reporter gene (Figure 1A),
was introduced into targeted ES cells with or without Cre-expression
plasmid. Only 0.5–1.0% of colonies regarded as non-recombined clone
stained blue with X-gal after introducing donor vector alone, whereas
20.6–24.3% of colonies showed lacZ expression upon co-introduction
of Cre plasmid. (B) Efﬁcient detection of correctly recombined clones.
Introduction of a donor vector, in which EGFP gene was included as
promoterless reporter gene, into ES cells together with the Cre plasmid
resulted in the appearance of hygromycin-resistant EGFP-ﬂuorescent
and -non-ﬂuorescent clones. Among them, 48 green ﬂuorescent
colonies (24 from H2-Tw3 and 24 from Rosa26) were picked and
analyzed by PCR. All the collected clones showed correct recombin-
ation (100%; Supplementary Table S2). (C) EGFP expression in
ES cells (left) and intestine of the mouse (right) containing a single
copy of the ‘CAG-EGFP-polyA’ cassette at the H2-Tw3 and Rosa26
loci. EGFP expression of both ES cells and intestines with RMCE
ex
allele was silenced (weak and mosaic). In the RMCE
ex allele that the
vector backbone and the bacterial resistance gene were removed by
FLPe administration, ES cells and intestines exhibited robust EGFP
ﬂuorescence.
Figure 3. PITT system. (A) PITT efﬁciency. A total of 11 constructs
were microinjected into fertilized eggs containing the targeted allele.
The numbers of founder transgenic mice obtained by PITT are
shown in red. (B) PCR screening of correct recombinants. Primer sets
used to amplify the junction regions and internal sequence of the donor
vector, are shown in red and blue, and the green arrowheads in
Figure 1A, respectively. Genomic junctions expected for an RMCE
and internal regions were ampliﬁed in the correct recombinants
(Nos. 3 and 16), while only the internal regions were ampliﬁed from
a pup with random integration (No. 2).
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founders, which was detected by PCR, varied from 0% to
63%, indicating transgene mosaicism (Supplementary
Table S5). These results validate the use of PITT for
routine transgenesis.
Stable and reproducible transgene expression in the
PITT mice
In the current evaluation of PITT, we used a series of
ﬂuorescent protein (FP) genes as transgenes. Expression
of the EGFP transgene expressed by the RMCE
"ex trans-
genic mice was readily detected under long-wave UV light
(365nm). We compared three H2-Tw3
CAG::EGFP mice, two
of which were independently generated via PITT while the
third was generated via ES cell targeting. All three dis-
played indistinguishable intensity of EGFP ﬂuorescence
(Figure 4A). The expression in the Rosa26
CAG::EGFP
mouse was higher than the H2-Tw3
CAG::EGFP mice
probably due to the position effect. EGFP expression
examined in spleen cells from the transgenic mice again
showed stronger ﬂuorescence in the Rosa26
CAG::EGFP
Figure 4. Fluorescent expression in targeted transgenic mice. (A) EGFP ﬂuorescence in H2-Tw3
CAG::EGFP and Rosa26
CAG::EGFP mice, containing a
single copy of the ‘CAG-EGFP-polyA’ cassette at the H2-Tw3 and Rosa26 loci, respectively. Three independent transgenic lines were obtained for
H2-Tw3
CAG::EGFP: two lines, labeled 2 and 3, were obtained by PITT, while the other, labeled 4, was obtained via RMCE in ES cells.
The Rosa26
CAG::EGFP line, labeled 5, was obtained via RMCE in ES cells. (B) Analysis of EGFP ﬂuorescence in spleen cells prepared from the
targeted transgenic mice. The numbers indicate mouse lines that correspond to those in (A). (C–E) Expression of ﬂuorescent genes in colored mice.
All lines containing a single copy of the ‘CAG-ﬂuorescent gene-polyA’ cassette at the Rosa26 locus exhibited ubiquitous and very bright ﬂuorescence
in blastocysts (C), newborn mice (D) and adult mice (E). (F) Ubiquitous and uniform ﬂuorescence expression in tissues of Rosa26
CAG::EGFP mice.
The left panels (a–i) are bright-ﬁeld images, and the right panels (a0–i0) are dark-ﬁeld ﬂuorescent images taken with green ﬁlters. Rosa26
CAG::EGFP
(g,g0–i,i0) mice showed generalized pancellular FP expression, while variegated EGFP expression was observed in tissues of the green mouse (d,d0–f,f0).
All transgenic mice were hemizygotes for the transgene.
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CAG::EGFP mice,
all of which displayed similar levels of EGFP expression
(Figure 4B). The current experiments also generated a
series of FP mice, expressing mCFP, EGFP, mCitrine,
mOrange or tdTomato with similar speciﬁcity
(Figure 4C–E and Supplementary Figure S5), and stably
for at least ﬁve generations. These results indicate that our
PITT system provides a reliable method to achieve stable
and reproducible transgene expression.
Strong and ubiquitous transgene expression in
Rosa26
CAG::FP mice
Transgenic mice that express FP in all tissues have been
widely utilized as essential tools for transplantation
studies and chimera experiments. Although several trans-
genic lines with ubiquitous expression of FP were
developed by random-integration-based transgenesis,
highly variegated expression of FP even among similar
cell types was noted. This undesirable feature of expres-
sion makes it difﬁcult to trace the origin of cells in trans-
plantation and cell-lineage analyses. We also compared
EGFP expression in Rosa26
CAG::EGFP mouse developed
in this study with that in commercially available
random-integration EGFP transgenic mouse (green
mouse) (30). The intensity of spleen-cell EGFP ﬂuores-
cence in the Rosa26
CAG::EGFP mouse was 2- to 3-fold
that in green mouse (Supplementary Figure S6), indicating
that our expression system drives very high levels of trans-
gene expression. In other organs, such as liver, kidney and
intestine, the EGFP expression in the green mouse was
weak and/or sporadic (Figure 4F, d,d0-f,f0), as described
previously (36). In contrast, Rosa26
CAG::EGFP mice
showed stronger and more uniform EGFP expression
(Figure 4F, g,g0-i,i0), which may prove critical in some
transplantation and chimera experiments. It is noteworthy
that all Rosa26
CAG::FP mice expressing other FP (e.g.
tdTomato) also exhibited similar strong and ubiquitous
expression pattern. These results emphasize the potential
utility of ﬂuorescent mice successively generated by PITT
as new reporter lines for cell lineage analysis.
Application of PITT to in vivo knockdown experiment
Finally, we assessed our strong and ubiquitous expression
system for generating miRNA-based knockdown mice. As
a test, we generated a mouse expressing artiﬁcial miRNAs
(Figure 5A) designed to interfere with the expression of
Tyrosinase (Tyr), a key enzyme in melanin synthesis.
The Rosa26
CAG::miR-Tyr mouse had light hair color,
reduced ear melanization, and a choroid coat compared
to wild-type littermates, consistent with reduced levels of
Tyr mRNA expression (Figure 5). The artiﬁcial miRNA
transgene did not seem to induce apparent adverse pheno-
type possibly due to not only off-target effect but also
oversaturation of the endogenous miRNA pathway (37),
suggesting that the Tyr miRNA expression level is high
enough to cause pigmentation phenotype but is low to
over-saturate the miRNA pathway. This desirable result
indicates the potential suitability of our strong and ubi-
quitous expression system for in vivo loss-of-function
experiments.
DISCUSSION
The method reported here is the ﬁrst report that describes
the successful generation of a series of targeted transgenic
mouse lines via PI. The PITT method described herein
showed approximately 0.6% and 4.3% efﬁciency of
correct and stable integration per injected embryo and
per newborn, respectively, and a high germ-line transmis-
sion rate (>85%). Thus, one germ-line-transmissible
targeted transgenic founder is expected to be derived
from every 200 embryo-injections on average, representing
a similar workload to that needed for generating transgenic
lines using the conventional PI-based transgenesis. It is
possible to further improve this efﬁciency by the injection
of synthetic Cre mRNA or recombinant Cre protein, or by
cell-permeable Cre treatment (38–40).
The PITT strategy has several advantages over previous
transgenesis techniques. First, unlike random-integration-
based transgenesis, the expression pattern of the transgene
is predictable, reproducible and stable. Even when several
Figure 5. Tyrosinase (Tyr) knockdown mouse. (A) The artiﬁcial miRNA for Tyr was expressed under the control of the CAG promoter at
the Rosa26 locus (Rosa26
CAG::miR-Tyr). (B) The levels of Tyr mRNA were quantitated by real-time RT-PCR analysis. Coat color (A), melanin in
ears (C) and choroid coat (D) were compared between the wild-type and Rosa26
CAG::miR-Tyr mice.
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the lines with adequate transgene activity is required and
only one targeted transgenic line is sufﬁcient for further
analysis. This provides cost saving, space and effort.
Second, our PITT method does not require ES cell ma-
nipulation once the seed mouse is established. Thus, it
saves not only money and effort for ES cell culture, but
also substantially reduces the time required to obtain
targeted transgenic lines ( 1–2 months). Third, in our
PITT method, circular plasmid DNA can be directly
injected into the fertilized eggs. Hence, unlike the conven-
tional PI-based transgenesis, it is not necessary to cut out
the transgene from the vector backbone and isolate the
insert by gel puriﬁcation.
A previous study investigated the feasibility of targeted
transgenesis via PI (33). The study showed successful
targeted integration of a transgene at an efﬁciency
comparable to ours. The system, however, suffered
from instability of integrated transgene conﬁguration
(uncontrollable orientation) due to the combination of
loxPs (wildtype loxP and its spacer variant, lox511),
leading to unstable transgene expression. In their study,
germ-line transmission was not examined. To our know-
ledge, our study is the ﬁrst report describing the estab-
lishment of a transgenic line generated by targeted
transgenesis via PI.
By applying the PITT method, we established a total of
18 transgenic lines, including color FP mice, with stronger
and more stable expression than currently available mice.
These FP mice will be available to the scientiﬁc commu-
nity. We also demonstrated that knockdown mice can be
readily generated by PITT by taking advantage of our
reproducible and highly efﬁcient expression system. We
also demonstrated that PITT is applicable to at least
two different chromosomal loci, and we expect similar
success with other loci and many loxP-tagged mice, such
as those generated by the International Gene Trap project
(http://www.genetrap.org/) (41,42). The PITT method
described herein could therefore provide a strong basis
for systematic generation of a variety of targeted trans-
genic lines, without going through ES cells, for reliable
transgene expression and for gene knockdown.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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